Everolimus-induced pulmonary toxicity: Findings on (18)F-FDG PET/CT imaging

The everolimus–exemestane combination is indicated in advanced breast cancer treatment and usually well tolerated. The objective of the study was to determine the frequency of everolimus lung side effects and investigate their imaging characteristics on positron emission tomography with 18F-fluoro-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dejust, Sebastien, Morland, David, Bruna-Muraille, Claire, Eymard, Jean-Christophe, Yazbek, Gabriel, Savoye, Aude-Marie, Papathanassiou, Dimitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200531/
https://www.ncbi.nlm.nih.gov/pubmed/30290608
http://dx.doi.org/10.1097/MD.0000000000012518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200531/
https://www.ncbi.nlm.nih.gov/pubmed/30290608
http://dx.doi.org/10.1097/MD.0000000000012518

Ejemplares similares